Hologic, a trusted channel partner of Global Marketing Services, is at the forefront of women’s health with advanced Aptima HPV Assays for early cervical cancer detection

Cervical cancer remains a serious health concern for women in Pakistan, with 5008 new cases and 3197 deaths reported annually. It ranks as the third most common cancer among women and the second most frequent among those aged 15 to 44. With nearly 88% of invasive cervical cancers linked to HPV-16 and HPV-18, early detection is crucial in preventing the disease before it becomes life-threatening. Hologic, Inc., a global leader in women’s health, offers advanced solutions like the ThinPrep Pap Test, which helps detect abnormal cervical cells, and the Aptima HPV Assays, which identify high-risk HPV infections most likely to cause cervical disease. At Global Marketing Services, Pakistan, we are committed to making these life-saving technologies accessible and affordable in Pakistan, ensuring that women receive the early diagnosis and care they deserve.